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Background: The purpose of this study was to evaluate the efficacy of a self-guided CD-ROM program
(“Headstrong”) containing cognitive-behavioral self-management strategies versus an educational CD-ROM program
for treating headaches, headache-related disability, and quality of life.
Methods: Participants were 35 children ages 7–12 years with migraine recruited from one university medical center
and two children’s hospital headache clinics. Participants were randomly assigned to complete the Headstrong or
educational control CD-ROM program over a 4-week period. Data on headache frequency, duration, and severity,
migraine-related disability, and quality of life (QOL) were obtained at baseline, post-intervention, and 3-months
post-intervention.
Results: At post-intervention, Headstrong resulted in lower severity (on a 10-point scale) than the control group by
child report (5.06 ± 1.50 SD vs. 6.25 ± 1.92 SD, p = 0.03, ES = 0.7). At 3-months post-intervention, parents reported less
migraine-related disability (on the PedMIDAS) in the Headstrong group compared to the control group (1.36 ± 2.06
SD vs. 5.18 ± 6.40 SD; p = 0.04, ES = 0.8). There were no other group differences at post treatment or at 3-months
post-intervention.
Conclusions: When compared to an educational control, Headstrong resulted in lower pain severity at post-
treatment and less migraine-related disability at 3-months post-intervention, by child and parent report respectively.
Headache frequency and quality of life did not change more for Headstrong versus control. Additional research is
needed on the Headstrong Program to increase its efficacy and to test it with a larger sample recruited from
multiple centers simultaneously.
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Cognitive-behavioral treatmentBackground
Headaches are one of the most common pain conditions
affecting children and adolescents. Worldwide, the preva-
lence of headache in children and adolescents has been
estimated to be as high as 58.4%, with migraine occurring
in up to 10% of young children [1]. Headaches can result
in substantial morbidity, including a high frequency of
school absences [2] and reduced overall quality of life [3].
Moreover, without early intervention, recurrences of
headaches in childhood can contribute to more* Correspondence: mrapoff@kumc.edu
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in any medium, provided the original work is pfrequent and disabling headaches during adolescence
and beyond [4].
Contemporary perspectives on the etiology and main-
tenance of primary headaches in children continue to be
founded on a model that integrates genetic and biological
predisposition with psychosocial context [5]. As such, in-
tegration of biobehavioral management with pharmaco-
logical interventions in a multidisciplinary treatment
approach is regarded as the optimal standard of care for
pediatric migraine [6,7]. Traditional biobehavioral inter-
ventions include relaxation, biofeedback, contingency
management, and cognitive pain coping strategies. Such
interventions are considered “empirically-supported treat-
ments” [8,9], with meta-analyses supporting reliablen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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[10,11].
To broaden access to effective cognitive-behavioral
treatment in children, CD-ROM and internet-based pain
management programs have been developed and tested
with children and adolescents with migraine [12-14] and
other recurrent or persistent pain conditions [15-17].
In general, these studies have found positive outcomes
forreducing pain relative to control conditions and the
results are similar to those found in traditional biobe-
havioral interventions delivered in face-to-face con-
tacts. Because of promising results in a pilot study of
the Headstrong program tested against a wait-list con-
trol group in young children (ages 7–12) [12], the
current randomized clinical trial was developed to
evaluate this Headstrong CD-ROM intervention (iden-
tical to the pilot study version as outlined in Table 1)
versus a more stringent control condition – one involv-
ing active educational content. The education condition
controls for contact time and other non-specific thera-
peutic factors while also including active components
of standardized education commonly provided in bio-
behavioral clinical care for pediatric headache [18,19].
We hypothesized that children with migraine headaches
who received the Headstrong program would demon-
strate greater improvement on headache outcomes (fre-
quency, intensity, and duration), lower levels of
headache-related disability, and better quality of life




Age (yrs, M, SD) 10.2
Gender (female, n,%) 15
Ethnicity (Caucasian, n,%) 16
Grade in school (M, SD) 4.6
CBCL total score (M, SD) 52.0
Mother's age (yrs, M, SD) 35.7
Father's age (yrs, M, SD) 37.9
Mother's ed (some college, n,%) 11
Father's ed (some college, n,%) 11 69%
Family income (>$50,000, n,%) 10
Headache pa
Migraine diagnosis (n,%) 17
Ibuprofen prescribed (n,%) 8
Nortriptyline prescribed (n,%) 2
Note: p-value for difference between groups, based on Mann–Whitney U or Fisher'sMethod
Participants
Institutional Review Board approval was granted for this
study at each recruitment site and informed consent was
obtained from the parent(s) or caregiver(s) of each par-
ticipant. A multi-center, randomized methodology was
used with participants being recruited from pediatric
headache clinics at one university medical center and
two children’s hospitals in the mid-west between De-
cember 2004 and March of 2010. Participants were not
run concurrently at all three sites, thus the reason for a
six year study period. Participants were stratified by age
(7–9 and 10–12) and randomly assigned following base-
line to one of the two groups (education control or
Headstrong). Participants met the following inclusion
criteria: (a) 7–12 years of age; (b) having migraine occur-
ring on the average at least once per week by parental or
child report and separated by symptom-free periods; and
(c) having a board-certified neurologist's diagnosis of mi-
graine with or without aura, using International Classifi-
cation of Headache Disorders [20]. Children were
excluded from the study if (a) their medical history and/
or neurological exam suggested that theirs were second-
ary headaches; (b) parents reported the child had been
diagnosed with a mental health condition or was receiv-
ing concurrent psychotherapy; (c) scores on the internal-
izing or externalizing scales of the parent-reported Child
Behavior Checklist [21] were in the clinical range at
baseline; or (d) the baseline headache diaries indicatedache parameters
l Headstrong
(n = 18) p
phics
1.5 10.2 2.0 0.91
88% 10 56% 0.06
94% 17 94% 1.00
1.6 4.4 2.1 0.91
7.8 49.9 11.0 0.60
6.2 37.9 8.1 0.50
5.8 41.8 8.1 0.17
65% 13 76% 0.71
12 67% 1.00
59% 15 83% 0.15
rameters
100% 16 89% 0.49
47% 12 67% 0.32
12% 4 22% 0.658
Exact test. M =mean, SD = standard deviation.
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(over a 14-day period). Participant descriptive statistics
are shown in Table 2.
Research design
Control group
Children in the control group continued to follow the
recommendations and prescriptions of their treating
neurologist. Typically, treatment included acute medica-
tions (e.g., NSAIDs, triptans, and muscle relaxants) and/
or preventative medications for children with a fre-
quency of headache greater than one per week (e.g., an-
ticonvulsants, antidepressants, beta-blockers).
Control participants received a developmentally appro-
priate educational CD-ROM program (see Table 1) con-
taining information about primary headaches (i.e., types
of primary headache, how headaches are assessed, typical
symptoms, typical triggers, prevalence, etiology, and the
multiple components of pain). The information con-
tained in the education CD-ROM was more in-depth but
similar to that contained in the first part of the Head-
strong program (i.e., Module #1: Education). The educa-
tion CD-ROM also covered health habits (e.g., sleep, diet,
physical activity), but no “active” psychological headache
therapies (e.g., relaxation, cognitive restructuring) were
contained in this program. Children were asked to
complete the program in 4 weeks, with approximately 1
lesson per day. The control CD-ROM controlled for the
amount of headache education the two groups received
and the time taken to completing the program. Parents
also were given a manual containing directions on how
to use the educational CD-ROM program, their role in
the program (e.g., how to assist with homework assign-
ments, how to complete headache diaries, etc.), lesson
overviews, and technical assistance information in case
their child had problems running the program. Children
were asked to record passwords obtained at the end of
each lesson; password sheets and homework assignment
sheets were then returned by mail so that adherence to
the program could be monitored.
Headstrong group
Participants in the Headstrong Group received the Head-
strong CD-ROM program (see Table 1) while continuing
to follow their treating neurologist’s recommendationsTable 2 Measures taken each week from beginning of study,
Phase Baseline Interven
Study week: 1 2 3 to
Child behavior checklist and demographics • No measur
Daily headache diary • •
PedsQL 4.0 •
PedMIDAS •and prescriptions. Children were asked to complete the
program in 4 weeks, with approximately 1 lesson per day
and were required to take simple quizzes to assess their
processing of the information presented. As with the
Control group, various passwords and homework assign-
ments were embedded within the program to ensure that
children were adherent in viewing and applying the
material.
The layout of the cognitive-behavioral component of
the CD-ROM intervention was similar to the education
component of the Control group (including graphics,
audio narration, music, clickable progress controls, pass-
words, homework assignments). However, the treatment
component also contained lessons on how to use various
empirically supported cognitive-behavioral treatments to
self-manage recurrent headaches. Specifically, week two
focused on relaxation methods (including a rationale
with narrated and illustrated instructions on guided im-
agery, deep breathing, and progressive muscle relax-
ation), week three focused on problem-solving and stress
management, and week four targeted pain behavior and
parental response to pain as well as a review of the pre-
vious weeks' lessons. A workbook accompanied the
Headstrong CD-ROM and contained all the supplemen-
tary material required for the self-management interven-
tion. Parents were also given a manual containing
directions on how to use the Headstrong program, their
role in the intervention (e.g., how to assist with homework
assignments, how to complete headache diaries, etc.),
lesson overviews, and technical assistance information in
case their child had problems running the program.
Procedures
Once children and families provided informed consent,
dependent measures were collected weekly via pre-paid
mailers over a two-week baseline phase. Standard med-
ical care was continued during baseline as throughout
the study. If the child or parent had questions about
headache activity or treatment during baseline, they
were asked to speak with the treating neurologist and/or
Headache Center Team. Contacts by research staff with
children and parents were limited to weekly telephone
calls to encourage consistent record keeping.
Following baseline, children were randomly assigned to
the control or treatment group. Children in the controlby phase
tion Post-intervention 3-months post-intervention
6 7 8 19 20
es taken
• • • •
• •
• •
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the treatment group received the Headstrong CD-ROM.
There were two versions of the educational and Head-
strong CD-ROM program; one for participants 7–9 years
and one for 10–12 year olds. Over the course of four
weeks, Control and Treatment children worked through
their respective lessons. Children were able to navigate
through the different lessons at their own pace and were
required to take simple quizzes to assess their processing
of the information presented. Various passwords and
homework assignments were embedded within the pro-
gram to ensure that children were going through the ma-
terial. Children were asked to record passwords obtained
at the end of each lesson; password sheets and homework
assignment sheets were then returned by mail so that ad-
herence to the program could be monitored. Weekly
phone calls continued during this intervention phase to
answer questions about the CD-ROMs and to remind par-
ticipants to complete and return password sheets. No
measures were collected during the four-week interven-
tion phase. Dependent measures were collected for two
weeks immediately following the intervention via pre-paid
mailers. Weekly phone calls continued during this two-
week post-intervention phase to encourage consistent rec-
ord keeping. Measures were then sent to families to be
completed during the last two weeks of the 3-month post-
intervention phase (see Table 2). Participants and their
parents completed all measures independently.
Child behavior checklist and demographics
Parents completed the Child Behavior Checklist [21] be-
fore other baseline measures were obtained to determine
if the child should be excluded from participation be-
cause of clinically significant elevations (above the 70th
percentile) on either the externalizing or internalizing
scale. At the beginning of baseline, demographic data
were obtained that included the child’s age, gender, eth-
nicity, grade in school, time since first experience of
headache symptoms, involvement in psychological ser-
vices, and current medications. We also collected infor-
mation on the parents’ age, marital status, education,
occupation, and income.
Headache diaries
Headache frequency, intensity/severity, and duration
were reported on daily paper and pencil-based diaries.
Just before going to bed, children recorded that day's
headache occurrences (if any), severity and duration.
Children reported whether or not they had a headache
that day by circling yes or no. Two items were available
each day in the event of more than one headache [22].
Children reported daily headache duration by recording
the time a headache started and the time it stopped.
Again, two items were available each day in the event ofmore than one headache, with the mean of the separate
durations being used in analyses (minimum = 0; max-
imum = 14 hr). Daily headache severity was rated using a
visual analog scale (VAS) ranging from 0 centimeters
(no pain) to 10 centimeters (severe pain) [12]. The scale
was illustrated with “pain face” anchors to help younger
children rate their pain severity. Two scales were avail-
able to children each day, in the event of more than one
headache, with the mean of the separate severities being
used in analyses. Parents reported the child's daily head-
ache occurrences, durations, and severities using the
same measures as those used by the children.
Headache-related disability
The Pediatric Migraine Disability Assessment (PedMI-
DAS) is the only specific measure of headache-related dis-
ability in the pediatric population. The measure quantifies
headache-related disability during the past three months
across school, home, sports and social activities [23,24].
Responses are summed and then graded as reflecting little
to none (0 to 10, Grade I), mild (11 to 30, Grade II), mod-
erate (31 to 50, Grade III), and severe disability (greater
than 50, Grade IV) [25]. PedMIDAS correlates signifi-
cantly with frequency, duration, and severity of headache
and is sensitive to treatment response. PedMIDAS total
score ranges from 0 (no headache-related disability) to
anything over 50 (severe headache-related disability [max-
imum score of 240].
Quality of life (QOL)
We used the fourth edition of the Pediatric Quality of
Life Inventory [26,27]. PedsQL 4.0's 23 items require
children to report on various aspects of physical func-
tioning (8 items), emotional functioning (5 items), social
functioning (5 items), and school functioning (5 items).
Respondents indicate the extent to which they are hav-
ing problems in each of these areas using a 0 (“never a
problem”) to 4 (“almost always a problem”) response
scale. Items are then reverse-scored and linearly trans-
formed to a 0–100 scale such that higher scores indicate
better quality of life. A parent-report version of PedsQL
4.0, identical to the child self-report version, was also
administered to obtain the parents’ perspectives on their
children’s quality of life. This scale has excellent psycho-
metric properties [28-30] and it can reliably document
the effects of pediatric migraine on QOL [3,31]. The
Total Scale Score has minimum = 0 (poorest quality of
life) and maximum = 100 (excellent quality of life).
Statistical analyses
Sample size calculation was based on improvements in
headache severity going from baseline to post-intervention.
The model utilized the Groups × Phases interaction in a
2 × 2 RM ANOVA with the anticipated effect being a
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for the Headstrong group versus no change for the control
group. Baseline values were estimated to be mean (SD) 5.0
(1.6) by pooling the values from three relevant studies
[12-14]. Seeking 80% power for the interaction and assum-
ing a two-tail alpha = 0.05 and a 0.60 correlation between
baseline and follow up, nQuery Advisor 7.0 (Statistical
Solutions, Saugus, Mass.) indicated n = 34 per group, total
N = 68. Assuming 15% attrition, the final target value was
set to n = 40 per group, total N = 80. The final group sizes
fell far short of those required by the sample-size deter-
mination (see Figure 1). Statistical analyses were therefore
necessarily restricted to univariate tests of differences be-
tween the two groups. There was insufficient power to
correct for multiple comparisons or to covary for poten-
tial confounding variables. Demographics are thus re-
ported only for descriptive purposes. With p < 0.05 we
ran one-tailed tests of treatment effects on the headache
measures and we augmented interpretation of theAssessed fo
Post-intervention analyzed (n=18)
3-months post-intervention analyzed (n=11) 
Lost to follow up (n=7)
Did not return phone calls (n=2)
Too busy/didn’t want to continue (n=3)
Allocated to intervention (n=40)
Received allocated intervention (n=18)
Did not receive allocated intervention (n=22)
























Figure 1 Consort diagram showing recruitment and retention of partobserved p-values with the corresponding effect sizes
(Cohen's ES = |M1-M2| ÷ SD pooled; [32]). Regardless of
the associated p-value, ESs between 0.50 and 0.80 were
considered to be in the medium to large range and there-
fore worthy of provisional discussion.
Results
Participants
The CONSORT diagram (see Figure 1) shows the num-
ber of clinic visits and number of potential participants
who were screened, the number of participants random-
ized, and the number who completed the protocol
through at least the post-interventions phase (Headstrong
n = 18; Control n = 17). We were required, by the IRB at
one site, to purge 24 participants from the database be-
cause of consenting errors, most of which involved the
witness and parent signing the form on different dates
(i.e., the parent had asked to take the consent form
home and was called by the research assistant andr eligibility (n=742)
Excluded (n=672)
Failed inclusion criteria (n=499)
Declined to participate (n=64)
Lost to follow up (n=6)
Did not return phone calls (n=1)
Too busy/didn’t want to continue (n=2) 
Allocated to control (n=30)
Received allocated intervention (n=17)
Did not receive allocated intervention (n=13)
Did not return phone calls (n=9)
Post-intervention analyzed (n=17)
3-months post-intervention analyzed (n=11)
mized (n=70)
icipants.
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back and therefore not witnessed by signature until some
few days later). The final sample was primarily Caucasian
(94%) with family income generally over $50,000 (71%),
both parents having at least some college education
(mothers 71%, fathers 68%), and the children diagnosed
most frequently with migraine headache (94%) and treated
with prescribed ibuprofen (57%) and/or nortriptyline
(17%). Table 3 shows the breakdown of these values by
group.Child reported outcomes
Complete results for the child reported outcome mea-
sures are shown in Table 4, including the results of com-
parisons between the education control and Headstrong
groups. The only statistically significant between-group
difference at post-intervention was in pain severity, with
the Headstrong group reporting significantly lower pain
severity than education controls (M = 5.06 vs. 6.25; p =
0.03; ES = 0.7). While moderate effects (ES = 0.70) were
also found for headache duration and disability at 3-
months post-intervention favoring the Headstrong
group (see Table 4), these differences were not statisti-
cally significant.Table 3 CD-ROM lessons for education control and headstron
Educational control lessons
Week 1 Headache education
1). Introduction
2). Types of headache
3). Prevalence of headache
4). Features of headache
5). How headache is diagnosed
Week 2 Cognitive-behavioral model of pain
1). Introduction to the pain puzzle
2). puzzle piece 1: Nociception
3). Puzzle piece 2: Thoughts
Week 3 Cognitive-behavioral model of pain
1). Puzzle piece 3: Feelings
2). Puzzle piece 4: Behavior
Week 4 Headache triggers
1). Introduction to headache triggers
2). Key headache triggers: diet and sleepParent reported outcomes
Complete results for the parent reported outcome mea-
sures are shown in Table 5, including the results of com-
parisons between the Control and Headstrong groups.
The only significant between-group difference was on
PedMIDAS at 3-months post-intervention, with the
Headstrong group having significantly less disability
compared to educational controls (means = 1.36 vs. 5.18;
p = 0.04; ES = 0.8). While a large effect (0.8) was also
found for headache duration in favor of the Headstrong
group at 3-months post-intervention (see Table 5), this
difference was not statistically significant. Note, however,
the much-reduced sample size (n = 22) at 3-months
post-intervention.
Discussion
Given the small number of participants who were eli-
gible and completed this randomized controlled-trial,
one could view the results as a second pilot study of the
Headstrong program using a control condition (educa-
tional control) more stringent than the wait-list control
used in the first plot study [12]. In the first study, signifi-
cant differences were observed between the groups fa-
voring Headstrong in headache frequency, severity, and
duration, but there were no differences in headacheg group
Headstrong lessons
Headache education & cognitive-behavioral model of pain
1). Introduction
2). Types of headache
3). Prevalence of headache
4). Features of headache
5). How headache is diagnosed
6). The pain puzzle
7). Headache triggers
Relaxation
1). Rationale for relaxation
2). How to use guided imagery
3). How to use deep breathing
4). How to use progressive muscle relaxation
Cognitive restructuring




1). Positive and negative pain behaviors
2). Importance of keeping active
3). Review of all lessons
Table 4 Children's results for headache outcomes, PedMIDAS, and PedsQL 4.0 at baseline, post-intervention and
3-months post-intervention
Baseline Post-intervention 3-Months post-intervention
TX CTRL TX CTRL TX CTRL
n 18.. . 17. . . 18. . . 17. . . 11. . . 11. . .
Headache frequency (% of days) Mean 41.09 40.67 31.28 32.14 21.43 18.18
Median 35.71 35.71 25.00 28.57 7.14 14.29
SD 22.67 28.79 28.24 22.23 23.47 17.60
p 0.48 0.46 0.36
ES 0.0 0.0 0.2
Headache duration (hr/episode) Mean 5.47 4.15 4.47 5.56 1.53 4.25
Median 4.04 2.86 3.71 4.25 1.50 2.65
SD 4.20 3.88 4.26 4.01 0.91 5.19
p 0.19 0.24 0.07
ES 0.3 0.3 0.7
Headache severity (10-point VAS) Mean 5.06 6.00 5.06 6.25 4.46 3.68
Median 4.61 5.90 5.42 6.06 4.33 3.75
SD 1.84 1.52 1.50 1.92 1.88 2.04
p 0.07 0.03* 0.20
ES 0.6 0.7 0.4
PedMIDAS total (0 to >50) Mean 13.26 15.53 7.82 12.29 0.91 3.50
Median 14.00 12.00 3.00 7.00 0.00 2.00
SD 9.69 10.08 10.59 12.94 1.45 4.86
p 0.25 0.14 0.05
ES 0.2 0.4 0.7
PedsQL total (0 to 100) Mean 82.10 79.35 83.70 80.69 84.88 85.67
Median 82.61 83.70 85.87 84.78 93.48 89.13
SD 12.18 11.55 12.07 14.36 18.22 14.32
p 0.25 0.26 0.46
ES 0.2 0.2 0.0
Note: TX = treatment group, Headstrong; CTRL = educational control group; n = number of participants; ES = Effect size (Cohen's d) for difference between
independent means. A value of 0.5 or greater indicates a medium effect size and 0.8 or greater a large effect size; p = 1-tail significance of the difference between
the two means directly above it. *A value of < 0.05 indicates a significant difference in means.
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statistically significant differences in favor of the Head-
strong only for severity at post-intervention by child rat-
ings and for PedMIDAS at 3-months post-intervention
by parent ratings. Though not statistically significant,
medium effect sizes favored the Headstrong group for
headache duration and PedMIDAS at 3-months post-
intervention by child ratings (both having ES = 0.70). Ef-
fect size also favored the Headstrong group on headache
duration at 3-months post-intervention by parent ratings
(0.80, or in the large range) even though the p-value = .08
was not significant. These differences in favor of the
Headstrong group might have been significant were the
groups as large as those specified in the study's sample-
size calculations but this cannot be proven in the current
study. Several differences between this study and theoriginal one, such as measurement differences, differences
in study timeline, and analytic differences, make for diffi-
cult direct comparisons of the results.
This study has several major limitations. First, the study
was under-powered according to pre-determined sample
size requirements. Generalizability of these findings is also
limited for the broader pediatric migraine population be-
cause of our exclusion of children with headaches less than
once per week and exclusion of children with mental health
conditions, which may lead to sample biases. These limita-
tions are somewhat tempered by our recruitment of chil-
dren and families from three different medical centers. Any
follow-up study must address the concern of recruitment
size by conducting a multi-site effort. Additional tech-
niques such as more regular and positive contact with par-
ticipants, creative incentives, reducing participant burden,
Table 5 Parent results for headache outcomes, PedMIDAS, and PedsQL 4.0 during baseline, post-intervention and
3-months post-intervention
Baseline Post-intervention 3-Months post-intervention
TX CTRL TX CTRL TX CTRL
n 18… 17… 18… 17… 11… 11…
Headache frequency (% of days) Mean 39.29 38.66 30.93 30.25 19.48 16.88
Median 35.71 35.71 25.00 28.57 7.14 14.29
SD 22.35 28.80 28.74 21.51 22.61 17.58
p 0.47 0.47 0.38
ES 0.0 0.0 0.1
Headache duration (hr/episode) Mean 5.69 3.72 5.63 5.25 1.76 3.94
Median 3.65 2.46 4.29 4.19 1.50 4.25
SD 4.58 3.49 4.17 3.58 1.23 3.95
p 0.10 0.40 0.08
ES 0.5 0.1 0.8
Headache severity (10-point VAS) Mean 6.37 6.52 6.15 6.84 4.57 5.63
Median 6.46 6.77 6.25 7.19 4.75 5.00
SD 2.01 1.92 1.56 1.37 1.98 2.30
p 0.42 0.10 0.17
ES 0.0 0.5 0.5
PedMIDAS total Mean 14.94 14.21 9.06 10.50 1.36 5.18
(0 to >50) Median 15.00 12.50 4.00 6.00 0.00 2.00
SD 10.63 8.41 11.82 11.24 2.06 6.40
p 0.41 0.36 0.04
ES 0.1 0.1 0.8
PedsQL total Mean 78.07 80.95 81.01 81.84 88.74 88.73
(0 to 100) Median 77.17 79.35 82.61 84.78 93.48 91.30
SD 14.17 9.81 12.36 15.95 11.28 7.75
p 0.25 0.43 0.50
ES 0.2 0.1 0.0
Note: TX = treatment group, Headstrong; CTRL = educational control group; n = number of participants; ES = Effect size (Cohen's d) for difference between
independent means. A value of 0.5 or greater indicates a medium effect size and 0.8 or greater a large effect size; p = 1-tail significance of the difference between
the two means directly above it. A value of < 0.05 indicates a significant difference in means.
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minimize attrition in the future [33]. In addition to the lim-
itations of sample size, the educational control CD-ROM
program had some potentially active treatment elements,
such as information on diet, sleep, and avoidance of head-
ache triggers. Our plans for the future are to modify the
education control program to avoid discussion of factors
that are known to mitigate headaches, such as emotional,
behavioral, and stress triggers. Finally, for the Headstrong
group the baseline PedMIDAS mean score was low (M =
13.3; considered to be Grade II, mild disability [25] while
their baseline PedsQL 4.0 mean score was high (82.10),
which is close to the mean of 83 found for a healthy sample
[30]. Thus, a favorable change on either of these secondary
measures was potentially limited by its proximity to the
scale limit.Despite the study's limitations, the effect sizes re-
ported here and results of our previous pilot study
combine to suggest that the Headstrong program may
positively influence children's headaches by providing
education about headaches and cognitive-behavioral
skills in managing headache symptoms. The Head-
strong program may also decrease headache-related
disability over the long-term by providing children
with additional tools for coping with migraines and
chronic tension-type headaches. In view of the results
of this study and the initial pilot study [12], we would
recommend the use of the Headstrong program in
clinical settings as an initial adjunctive treatment for
pediatric headaches in combination with medications.
Some patients may require additional face-to-face cognitive-
behavioral treatment if Headstrong does not produce
Rapoff et al. The Journal of Headache and Pain 2014, 15:12 Page 9 of 10
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and/or severity.
Conclusions
When compared to an educational control, Headstrong
resulted in lower pain severity at post-treatment and less
migraine-related disability at 3-months post-intervention,
by child and parent report respectively. Headache fre-
quency and quality of life did not change more for Head-
strong versus control. Additional research is needed on
the Headstrong Program to increase its efficacy and to
test it with a larger sample recruited from multiple cen-
ters simultaneously.
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